Dr James Winterburn

The Winterburn Group has well established research interests focused on developing efficient manufacturing methods for biobased chemicals, via a bioprocessing and biochemical engineering route. Including: Process development and intensification for production of biosurfactants and biopolymers; Added value bio-based chemicals production; By-products and waste stream valorisation; Engineering novel fermentation and separation processes; Novel bioseparations; Engineering biology. Successfully commercialised patented biosurfactant production and separation technology via Holiferm, spun out from The Winterburn Group in 2018. Holiferm employs >50 FTE, with a 1000 tpa biosurfactant manufacturing facility established in Ocean Park Wallasey, UK, supported by a £18.5M Series B venture capital funding round from Rhapsody Venture Partners and Clean Growth fund.